ViroPharma launches Plenadren in Denmark as first market
This article was originally published in Scrip
Executive Summary
ViroPharma has launched its treatment for adrenal insufficiency Plenadren (hydrocortisone) in Denmark, the first market worldwide, with further EU launches expected before the end of 2012 including the UK, Norway and Germany. Some country launches are anticipated within the next few weeks.